Compared to Estimates, Alkermes (ALKS) Q4 Earnings: A Look at Key MetricsZacks Investment Research • 02/15/24
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2023 and Provides Financial Expectations for 2024PRNewsWire • 02/15/24
Exploring Analyst Estimates for Alkermes (ALKS) Q4 Earnings, Beyond Revenue and EPSZacks Investment Research • 02/12/24
Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 15, 2024PRNewsWire • 02/08/24
Alkermes (ALKS) to Report Q4 Results: Wall Street Expects Earnings GrowthZacks Investment Research • 02/08/24
Alkermes (ALKS) Stock Falls Amid Market Uptick: What Investors Need to KnowZacks Investment Research • 02/08/24
Alkermes (ALKS) Registers a Bigger Fall Than the Market: Important Facts to NoteZacks Investment Research • 01/27/24
Alkermes Announces Topline Results From Long-Term, Open-Label Safety and Durability of Treatment Effect Study of LYBALVI® (olanzapine and samidorphan)PRNewsWire • 01/03/24
Alkermes (ALKS) Outperforms Broader Market: What You Need to KnowZacks Investment Research • 12/23/23
Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo NordiskPRNewsWire • 12/14/23